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The mechanism by which fibrogenic particulates induce inflammation that can progress to lung
fibrosis is uncertain. The alveolar macrophage (AM) has been implicated in the inflammatory
process because of its function and reported release of inflammatory mediators when isolated
from fibrotic patients. It has been recently shown that fibrogenic, but not nonfibrogenic,
particulates are highly potent in inducing apoptosis of human AM. In this study, we tested the
hypothesis that fibrogenic particulates could shift the phenotypic ratio of human AM to a more
inflammatory condition. The macrophage phenotypes were characterized by flow cytometry
targeting the RFD1 and RFD7 epitopes. Results demonstrated that chrysotile and crocidolite
asbestos, as well as crystalline silica, but not titanium dioxide or wollastonite, increased the
RFD1 + phenotype (inducer or immune activator macrophages) and decreased the RFD1+RFD7+
phenotype (suppressor macrophages). These results provide a mechanistic explanation that may
link apoptosis (namely, suppressor macrophages) to a shift in the ratio of macrophage
phenotypes that could initiate lung inflammation. Environ Health Perspect 105(Suppl
5):1139-1142 (1997)
Key words: RFD1, RFD7, inflammation, fibrosis, apoptosis
Introduction
Inhalation offibrogenic particulates such as
asbestos and silica results in the development
oflung inflammation that can progress to
lung fibrosis (1). Although these particulates
have long been known to cause lung fibrosis,
there is as yet no comprehensive understand-
ing ofthe molecular and cellular events that
lead to fibrosis. Much work in this area has
focused on the alveolar macrophage (AM).
The rationale behind this is 2-fold. First,
AM would be expected to be among the first
cells to encounter asbestos and silica as they
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are the first line of lung defense against
microbes and are responsible for phagocyto-
sis ofinhaled foreign material (2). Second,
AM taken from fibrotic patients release a
variety ofproinflammatory mediators capa-
ble ofstimulating fibroblast proliferation and
collagen synthesis, which are hallmarks of
fibrosis (3). For example, a previous study
has shown that even in the absence ofclini-
cal evidence oflung fibrosis, subjects exposed
heavily to asbestos for a number ofyears had
AM that were much more active in releasing
inflammatory mediators than matched sub-
jects with lower asbestos exposures (4).
Therefore, macrophage activation appears
to be consistent with the development of
inflammation andfibrosis.
To study the mechanism(s) of macro-
phage activation by fibrogenic particulates,
a number of laboratories, including our
own, have attempted to replicate human
AM activation by these particulates.
Although there is some increased release of
inflammatory cytokines in response to sil-
ica and asbestos, the release is orders of
magnitude less than that observed using
macrophages taken from fibrotic patients
(4). This suggests that some other factor or
process may be involved with particulate
activation ofmacrophages.
Several studies have demonstrated the
presence of distinct macrophage pheno-
types within the AM pool obtained by
bronchoalveolar lavage from human sub-
jects. The macrophage phenotypes have
been described on the basis ofexpression of
RFD1 and RFD7 epitopes found on
human AM (5,6). RFD1 corresponds to a
28- to 33-kDa protein within the MHCII
complex while RFD7 corresponds to a 77-
kDa protein found intracellularly and on
the cell surface (6). Using these markers,
Poulter and colleagues have classified
RFD1+ AM as those strongly stimulating T
lymphocytes in allogenic-mixed lympho-
cyte reactions, dendriticlike, nonadherent
to glass, weakly phagocytic, and containing
low amounts of intracellular fluorescent
material (7-9). RFD7+ AM are mature
phagocytic cells (9), and RFD1+7+ AM
function as suppressor cells (7,9). Both
RFD7+ and RFD1+ AM have significant
amounts of intracellular fluorescent mater-
ial, suggesting phagocytic activity.
RFD1+7+ cells are very poor stimulators of
allogenic mixed lymphocyte reactions and
were reported to actively repress the T-cell
stimulatory capacity of RFD1+ AM (7,9).
Furthermore, addition of RFD1 mono-
clonal antibodies (MoAb) inhibits RFD1+
AM-mediated T-cell stimulatory activity
(10). Studies of these AM phenotypes in
patients with various inflammatory diseases
strongly suggest that shifts in phenotypes
could play a role in disease progression
(7,11), and regulation ofthese phenotypes
could be important in altering disease pro-
gression and/or outcome. Therefore, if
fibrogenic particulates cause a shift in these
populations to a higher ratio of RFD1+ to
RFD1+7+ cells, we propose that it could
explain in vitro and in vivo findings that a
shift in phenotype is required prior to a net
change in AM activity. An increase in
RFD1+ cells would increase T-cell activa-
tion, resulting in interferon-y release and
development ofthe inflammatory cascade.
A potential mechanism for change in
macrophage phenotype may be apoptosis
of the suppressor population. The ability
offibrogenic particulates, but not of non-
fibrogenic particulates, to cause human
AM apoptosis has been described recently
(12,13). Apoptosis was evident at concen-
trations of particulates well below those
causing any evidence ofother forms ofcell
injury and below doses causing human
AM release ofinflammatory cytokines (4).
In addition, another fibrogenic agent,
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bleomycin, was reported to be a potent
inducer ofapoptosis in human AM (14).
Whether this defines a pattern remains to
be determined. Nevertheless, apoptosis of
suppressor macrophages provides a mecha-
nism that could cause a relative increase in
the effector to suppressor macrophage ratio.
The present study was designed to test
the hypothesis that fibrogenic particulates
such as asbestos and silica could affect the
phenotype ratio of human AM in vitro.
Human AM were incubated with chrysotile
(CHR), crocidolite (CRO), crystalline sil-
ica (SIL), wollastonite (WOL), and tita-
nium dioxide (TIO), then examined by
flow cytometry for changes in expression of
RFD1 and RFD7 surfacemarkers.
Materials and Methods
C Cultures
Human AM were obtained by broncho-
alveolar lavage of normal, nonsmoking
adult volunteers ofeither gender as previ-
ously described (15). Instillations of240 to
300 ml sterile saline resulted in recoveries
of200 to 260 ml oflavage fluid that was
kept at 40C until cells were isolated from
the lavage fluid by centrifugation. The
saline supernatant was aspirated and dis-
carded, and the cell pellet was resuspended
in a small volume (1-5 ml) of HEPES-
buffered medium 199 (GIBCO BRL,
Gaithersburg, MD) with 10% fetal bovine
serum (Sigma Chemical Co., St. Louis,
MO) and antibiotics (50 U/ml penicillin,
50 pg/ml gentamycin, and 50 pg/ml strep-
tomycin). The cell count was determined
with a ZBI Coulter Counter (Coulter
Electronics, Hialeah, FL). Lavages yielded an
average of 20x 106 cells that were greater
than 92% AM, as verified by Leukostat stain-
ing (Fisher Scientific, Houston, TX).
Viabilitywas greater than 90% as determined
bytrypan blue exclusion.
Cells (1 x 106 cells/ml) were cultured at
370C in the media described above for 4 or
24 hr in the presence of no particulate
(CNT), CHR (25 /ml), CRO (75 pg/ml),
SIL (133 pg/mi), TIO (60 pg/ml), and
WOL (200 /ml). Cell cultures were main-
tained in suspension by slow end-over-end
tumbling (Labquake Shakers, Labindustries,
Berkeley, CA) in sterile polypropylene tubes
(PGC Scientific, Gaithersberg, MD) at
37°C in a water-jacketed CO2 incubator
(Queue, Parkersburg, WV).
Particuates
Two forms of asbestos were used in this
study: CHR (Union Carbide RF144, 1-5
pm length) and CRO (UICC standard
reference, 2-10 pm length). SIL (average
size 5 pm) was acid-washed with min-U-sil-
5 from Pennsylvania Glass Sand Corp.
(Pittsburgh, PA). TIO (average particle
diameter 0.45 pm) was purchased from
Particle Information Services (Kingston,
WA). WOL was provided by NYCO
Minerals (Willsboro, NY). Particulate sus-
pension concentrations were based on rela-
tive surface areas for the various particulates
(25 pg/ml CHR is approximately the same
surface area as 75 pg/ml CRO, 200 pg/ml
WOL, 133 pg/ml SIL and 60 pg/ml TIO.
Surface areas for asbestos were obtained
from Timbrell et al. (16), WOL from
information provided by the supplier, and
surface areas were calculated for SIL and
TIO based on particle size. Relative surface
areas were selected as a measure ofequiva-
lency based on equal involvement of the
AM plasma membrane upon contact with
the particles. The upper limit of the sus-
pension concentration was determined by
the relative cytotoxicity of these fibers in a
24-hr cell culture. At concentrations
greater that 25 pg/ml, CHR decreased cell
viability, and it became the concentration-
limiting factor. All particulates were
dispersed in saline before use by 10 pas-
sages through a syringe fitted with a
25-gauge needle. Stock suspensions ofpar-
ticulates were prepared fresh just before
their addition into AM cell culture.
Immunoining
At the termination ofcell culture (4 or 24
hr) all cultures were centrifuged in an
Eppendorf Microcentrifuge 5415C
(Brinkman Instruments, Engelsdorf,
Germany), at maximum speed (12,000xg)
for 20 sec. The culture media was aspirated
and the cell pellet (5 x 105 cells) was resus-
pended in 500 pl phosphate-buffered saline
(PBS) with 3.5% bovine serum albumin
(BSA). The monoclonal antibodies to
RFD1+ (murine IgM) and RFD7+ (murine
IgG1) surface antigens (Serotec, Kidington,
Oxford, England) were added concomi-
tantly at a 1:200 dilution (2.5 pl in 500
pI1). This mixture was incubated for 30 min
at room temperature. The incubation was
terminated as stated above with centrifuga-
tion and aspiration. The cell pellet was
then washed 3 times in PBS (resuspension,
centrifugation, and aspiration 3 times).
The cell pellet was then again suspended in
PBS/BSA buffer and the fluorescein anti-
mouse IgM and the R-phycoerythrin
antimouse IgG (Vector Labs, Burlingame,
CA) were added concomitantly at a 1:100
dilution (5 pl in 500 pl) and incubated 30
min at room temperature. This incubation
was terminated and washed 3 times in PBS
as described above. The cell pellet was then
suspended in 1% formaldehyde (PBS
buffered) and stored at 40C before flow
cytometric analysis. Flow cytometry was
performed on a FACScan flow cytometer
(Becton-Dickinson, Bedford, MA) using
Consort 30 software. Using forward and
side scatter ofthe total cell population, gates
were drawn to include macrophages based
on size and granularity of the cells. The
instrument was calibrated with fluorocein-
isothiocyanate (FITC)- and phycoerythrin
(PE)-coated beads to compensate for any
overlap within the green and red fluores-
cence wavelengths. Cells stained without
the inclusion ofprimary antibodies resulted
in no significant staining.
StatistalAnalysis
Because ofvariances in the RFD pheno-
types of individuals, data were normalized
to control values for each subject. Data are
expressed, therefore, as a ratio ofcontrol,
with the control value always equal to 1.
For statistical analysis, particulate expo-
sures were categorized as either fibrogenic
(CHR, CRO, and SIL) or nonfibrogenic
(TIO and WOL). The statistical compari-
son between these two categories at each
time point (4 and 24 hr), and for each phe-
notype (RFD1+, RFD1+7+) was performed
by a one-tailed Mann-WhitneyTest.
Results
Normal DistributionofHuman
AlveolarMacrophage Phenotps
Much of the data from other laboratories
characterized the distribution ofthe RFD1
and RFD7 epitopes on human AM using a
fluorescence microscope. Since this study
was done using flow cytometry to examine
surface markers, the normal distribution
was determined by this analysis. The
results from analysis of 12 normal subjects
are shown in Figure 1. The percentages of
RFD1+, RFD1+ 7+, RFD7+ were 5, 43,
and 5, respectively. Previous studies have
reported distributions of 11.4, 45.2, and
43.3 for RFD1+, RFD1+7+, RFD7+,
respectively (17). However, those analyses
were performed using immunohistochemi-
cal staining in which both surface and intra-
cellular markers are stained. It has been
reported that RFD1 is primarily surface and
RFD7 is intracellular and surface (5).
Therefore, the difference in the results sug-
gest that RFD7 on double-stained cells is on
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subjects. AM were examined for surfai
RFD1 and RFD7 epitopes by flow
described in Materials and Methods.
sentthe mean ± SEM for n=12 subject
the surface, whereas RFD7 on s
cells is primarily intracellular.
EffectofParticulates on Hu
AlveohrMacrophage Phenc
To test the hypothesis that
particulates cause a shift in
phenotypes, we incubated no
AM with three fibrogenic par
pg/mi CRO, 25 pg/ml CH
pg/ml SIL) and two nonfibrog
lates (60 pg/ml TIO and 200 t
for 4 and 24 hr and then AM
were examined by flow cytc
results are shown in Figure 2
phenotypes RFD1+, RFD1+7+,
respectively. In each case the re
malized against cells incubated
particulates. As a group, the flt
ticulates caused a significant
RFD1+ cells that persisted for
significant decrease in RFD1
hr that became more evident
significant decrease in the RFI
also observed with the fibrog
lates at 4 and 24 hr. These rel
strate that fibrogenic particu
shifts in the macrophage pher
nonfibrogenic particulates h-
with the exception ofWOL,wI
to cause a short-term increase
ble-positive cell phenotype tha
normal by24 hr.
Discussion
The capability ofa number of
genic particulates (chrysotile
and crystalline silica) but not r
particulates to cause apoptos
AM has been recently descril
Another potent but unrelated fibrogenic
agent, bleomycin, also induces apoptosis
of human AM (14). This correlation
between apoptosis of human AM and
development offibrosis suggests that apop-
tosis could be an early event in the develop-
ment of lung inflammation. However,
apoptosis usually does not result in the
development of inflammation, especially
since programmed cell death is required for
normal development (18). Therefore, the
potential association between human AM
7+ apoptosis and development ofan inflam-
matory condition required further clarifica-
tion. The results from the presentstudymay
types in normal provide that association.
Ice expression of The lung is constantly exposed to a
cytometry as wide variety of foreign substances that
The data repre- impinge on the epithelial surface of the
's. respiratory tract. Therefore, in order to
prevent constant sensitization to these non-
single-stained pathogenic substances and antigens, a non-
specific immune suppression mechanism
must exist. This suppression of the lung
man mucosa can be explained in part by the
DtlYPs presence of a relatively high fraction
t fibrogenic (40-50%) ofRFD1+7+ AM, which down-
macrophage regulate the immune response in the lung
irmal human while providing nonspecific host defense
rticulates (75 (8). The lung also contains a low fraction
ER, and 133 (5-10%) ofan immune active phenotype,
,enic particu- characterized as being RFD1+ (17).
4g/ml WOL) Observations consistent with the role of
I phenotypes these two cell populations are increases in
metry. The the RFDI+/RFDI+7+ ratio reported in
2a-c for AM lung inflammatory conditions such as
andRFD7+, asthma and sacroidosis (11,17,19,20).
sults are nor- Therefore, the ability ofxenobiotic agents
without any to cause a shift in macrophage phenotypes
brogenic par- should correlate with their ability to induce
t increase in lung inflammation.
24 hr and a The results from the present study indi-
7+ cells by 4 cate that fibrogenic, but not nonfibrogenic
by 24 hr. A particulates, increase the RFDI+/RFDI+7+
D7+ cells was ratio consistent with that observed in
;enic particu- human lung inflammatory conditions.
sults demon- Because there was an increase in RFD1+
Llates caused and a decrease in RFD1+7+ cells, the net
notypes. The change in the ratio was approximately
ad no effect, 4-fold. Furthermore, the lack of effect of
hichappeared nonfibrogenic particulates suggests that the
e in the dou- changes observed with the fibrogenic par-
.t returned to ticulates was not due to a particulate-
induced artifact affecting flow cytometry.
Therefore, there was an excellent correla-
tion between the fibrogenic potency and a
several fibro- shift in macrophage phenotype to a more
, crocidolite inflammatory ratio consistent with the
ionfibrogenic disease etiology.
sis ofhuman The effects of the fibrogenic particu-
bed (12,13). lates were progressive with time, especially
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Figure 2. Change in AM phenotypes after exposure to
particulates. AM were incubated for 4 hr and 24 hr
with 75 pg/ml CRO, 25 pg/ml CHR, 133 pg/ml SIL, 60
pg/ml TIO, 200 pg/ml WOL, or without any particu-
lates. After the incubation period, cells were examined
for surface expression of RFD1 and RFD7 epitopes by
flow cytometry as described in "Materials and
Methods". The data are expressed as the change rela-
tive to cells incubated withoutany particulates(1=100%
of control) for (A) RFD1+, (B) RFD1+7+, and (C) RFD7+.
The data are expressed as the mean ± SEM for n=10
(for CRO and SIL) and n=8(for CHR, TIO, andWOL).
on the RFD1+7+ population. This outcome
is consistent with the time frame ofapop-
tosis caused by these particulates which ini-
tiates within a few hours, but progresses
with time (12,13). It still remains to be
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established that the RFD1+7+ population is
more sensitive to apoptosis than the
RFD1+ cell population. These conclusions
are based on the assumption that the
macrophage phenotypes are static. However,
ifthe macrophage phenotypes are reversible,
then it is possible that fibrogenic particulates
could change the phenotype without having
to evoke apoptosis. Further studies will be
needed to evaluate this possibility. Although
work in other laboratories has demonstrated
ashift in thesepopulations duringinflamma-
tory conditions in the lung (11,17,19,20), it
remains to be determined whether the same
also holds for lung fibrosis. Nevertheless, it
appears from this study that fibrogenic
particulates can cause a rapid shift in phe-
notypes and could precede inflammation,
i.e., the shift in phenotypes is a primary
rather than a secondary event. The results
also indicated that fibrogenic particulates
decreased the RFD7+ phenotype. Whether
the presence ofthe RFD7 epitope could be
important in apoptosis by fibrogenic
particulates remains to be determined.
In summary, these results provide a
mechanistic explanation to link a number
offindings. The results indicate that fibro-
genic particulates cause a shift in macro-
phage phenotypes to a more inflammatory
condition without having to induce inflam-
mation by themselves. This is consistent
with the general lack of any significant
release of inflammatory mediators from
human AM incubated with particulates in
vitro. Therefore, the altered macrophage
phenotype ratio, in combination with other
immune cells, would generate an inflamma-
tory condition, which explains the highly
active macrophages obtained from fibrotic
patients. These findings indicate that new
approaches to therapy need to be explored,
with agents that could restore the normal
phenotype balance and ablate the progressive
inflammatory condition in fibrosis.
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